A2058

Methanol

Alizarin (10^{−5} M)

Purpurin (10^{−5} M)


Avg. Migration (μm)

Mean

5.347 ± 0.16

8.719 ± 0.25**

22.667 ± 0.82***

Slope

0.034 ± 6.82E−4

0.056 ± 7.03E−4

0.170 ± 0.01***

R

0.955

0.981

0.933

Adj. Rsquare

0.912

0.963

0.870

Avg. migration directness (migration vs motility)

Mean

0.110 ± 0.01

0.100 ± 0.01

0.196 ± 0.01**

Slope

−6.40E−4 ± 7.83E−5

−7.14E−4 ± 8.38E−5

−2.30E−4 ± 6.79E−5**

R

0.468

0.482

0.214

Adj. Rsquare

0.215

0.229

0.042

Avg. motility (µm)

Mean

75.229 ± 2.63

125.627 ± 4.94**

104.172 ± 3.99*

Slope

0.587 ± 0.01

1.099 ± 0.01***

0.890 ± 0.01**

R

0.998

0.997

0.998

Adj. Rsquare

0.996

0.995

0.996

Avg. motility speed (µm/h)

Mean

79.931 ± 1.14

134.900 ± 2.44**

104.630 ± 4.75*

Slope

0.063 ± 0.01

0.279 ± 0.03***

0.045 ± 0.06

R

0.248

0.514

0.042

Adj. RSquare

0.057

0.261

0.002

 Effect of treatment with alizarin (10^{−5} M) and purpurin (10^{−5} M)
 Data shown in the table represent variables and ± S.D. values calculated for 50 cell/group in 240 consecutive frames
 The ‘Mean’ values are expressed as dimensions (μm, μm/h) shown in the subheaders of the table
 The slope values are expressed as dimensionless values to describe the changing rate of Mean values in the 2 h’ time interval of treatments
 R and Adj. RSquare represent data of linear regression analysis to describe trends of variables belonging to the parameters calculated
 The level of significance is shown as follows: * p < 0.05; ** p < 0.01; *** p < 0.001